Airway remodeling due to increased airway smooth muscle (ASM) mass, likely due to enhanced migration and proliferation, has been shown to be highly associated with decline in lung function in asthma. Thymic stromal lymphopoietin (TSLP) is an IL-7-like, pro-allergic cytokine that has been shown to be necessary and sufficient for the development of allergic asthma. Human ASM (HASM) cells express TSLP receptor (TSLPR), the activation of which leads to enhanced release of proinflammatory mediators such as IL-6, CCL11/eotaxin-1, and CXCL8/IL-8. We show here that TSLP induces HASM cell migration through STAT3 activation since lentiviral-shRNA inhibition of STAT3 abrogated the TSLP-induced cell migration. Moreover, TSLP induced multiple cytoskeleton changes in HASM cells such as actin polymerization, cell polarization, and activation of small GTPase Rac1. Collectively, our data suggest a pro-migratory function of TSLP in ASM remodeling and provides better rationale for targeting TSLP/TSLPR pathway for therapeutic approaches in allergic asthma.
A irway remodeling is a cardinal feature in allergic asthma that culminates in the form of abnormal epithelium, subepithelial thickening, mucus gland hypertrophy, alteration in extracellular matrix deposition, and increase in airway smooth muscle (ASM) mass. ASM remodeling has been shown to be one of the most crucial factors that correlate with decreased lung function in asthma 1 . Proposed mechanisms of ASM remodeling include enhanced migration, proliferation (hyperplasia), and increased size (hypertrophy) of ASM cells. Although the source of migrating ASM cells in airways remain a matter of debate (e.g. from circulating fibrocytes, the original deeper ASM layer, or from bone marrow/lung-derived mesenchymal stem cells), the process of migration has been proposed extensively to underlie, at least in part, the airway remodeling and thus the pathogenesis of asthma 2 . Although these structural changes are known to cause substantial airflow limitation in asthma 3 , they are not reversed by currently availably asthma therapies. Thus, there is a stern need to identify the novel triggers and mechanisms of ASM migration.
Thymic stromal lymphopoietin (TSLP) is a pro-allergic, IL-7-like hematopoietic cytokine that has been shown to be necessary for the development of allergic asthma in some animal models 4 . TSLP exerts its biologic effects through a heterodimeric TSLP receptor (TSLPR) composed of TSLPR subunit and IL-7Ra 5 . Animal models overexpressing TSLP exhibit enhanced susceptibility to and the intensity of allergic airway disease while the mice lacking TSLP receptor (TSLPR2/2) had considerably attenuated disease, discussed in 6 . The identification of triggers of TSLP expression and its cellular targets is an emerging area of investigation. In airways, TSLP is produced by epithelial cells, mast cells, ASM cells, and fibroblasts 7 . TSLP activates immature CD11c1 dendritic cells (DC) to express the costimulatory ligand OX40L, which renders DCs to become mature and migrate to the draining lymph nodes. These DCs then stimulate the naive CD41 T cells via binding to the OX40, to differentiate into inflammatory type 2 (Th2) cells producing IL-4, IL-5, IL-13, tumor necrosis factor (TNF), and no or little IL-10 8 . In addition, TSLP favors Th2 environment by directly enhancing the cell proliferation, STAT5 phosphorylation, and expression of anti-apoptotic factor Bcl-2 in Th2 cells 9 . TSLP is highly expressed in ASM bundles from asthma 10 and COPD patients 11 . HASM cells were recently recognized to express a functional heterodimeric receptor TSLPR 12 ; and the activation of HASM via TSLPR leads to proinflammatory cytokine IL-6, chemokines CXCL8/IL-8 and CCL11/eotaxin-1 release, and increase in intracellular Ca 21 7,12,13 . Interestingly, TSLP was shown to induce migration in DCs 14 , suggesting a novel physiological function of TSLP that could potentially promote inflammation. However, the effect of TSLP on ASM migration remains unknown. We show here, for the first time, an increased HASM cell migration in response to TSLP stimulation, and uncover some of the putative signaling mechanisms involved in this process.
Results TSLP induces migration in HASM cells. To assess whether TSLP can affect HASM cell migration, Boyden chamber assay for cell migration was performed on primary HASM cells. We found that the recombinant human TSLP (1-10 ng/ml) induces HASM cell migration (p , 0.001, n 5 4, Fig. 1A) . One of the physiological stimuli of HASM cell migration, platelet derived growth factor-BB (PDGF-BB) was used as a positive control which induced highly significant increase in the number of migrated HASM cells (p , 0.001, n 5 4, Fig. 1A, B) . Taken together, our data shows that TSLP can elicit HASM cell migration.
TSLP-induced HASM cell migration requires STAT3 activity. We then sought to investigate the underlying signaling mechanisms of TSLP-induced cell migration. We have previously established that Signal transducer and activator of transcription 3 (STAT3) but not STAT5 is phosphorylated and only STAT3 activation is required for TSLP-induced HASM cell synthetic functions 12 . Therefore, we performed lentiviral-shRNA-mediated inhibition of STAT3 in our HASM cells 12 and (See Methods section). As shown in Fig. 2A lentiviral-shRNA inhibited the total STAT3 expression significantly. We observed that the TSLP-induced cell migration was nearly abolished in STAT3-shRNA-transduced cells (p . 0.05 compared to unstimulated control, n 5 3, Fig. 2C, D) . The scrambleshRNA-transduced HASM cells exhibited normal migration response (p , 0.05, n 5 3, Fig. 2B, D) which was similar to wildtype/nontransduced HASM cells in response to TSLP stimulation in Fig. 1 , suggesting the specificity of STAT3 targeting by shRNA transduction. It has been shown earlier that STAT3 serves as a signature element in PDGF signaling, at least in HASM cells. In agreement with these observations 15 , STAT3 inhibition also led to complete loss of PDGF-induced HASM cell migration in our study (Fig. 2C, D) , also strengthening our experimental approach. Therefore, our data clearly shows that TSLP and PDGF induce HASM cell migration in a STAT3-mediated manner.
TSLP induces cytoskeletal changes to induce HASM cell migration. Reorganization of actin cytoskeleton is a fundamental mechanism in cell motility and migration. To further unravel the potential mechanisms of actin substructures involved in migration process, we employed cytoskeleton staining of HASM cells by using phalloidinAlexa FluorH 488 (Invitrogen, Burlington, ON) (See Methods section). As shown in representative micrographs of phalloidin-stained cells in Fig. 3A ; whereas untreated cells showed flattened shapes, both TSLP (10 ng/ml), and PDGF (10 ng/ml)-treated cells showed polarized shapes. In other words, TSLP and PDGF induced lamellipodia structure formation, indicative of polymerized actin required for cell migration 16 . Consistent with the proportion of migrated cells in Fig. 1 and 2, TSLP induced polarization in 25.29 6 1.180% and PDGF in 44.75 6 2.195% of the cells (p , 0.0.01 and p , 0.001, respectively; n 5 3) compared with that in unstimulated 5.670 6 1.470% cells (Fig. 3 B) .
TSLP induces Rac1 activity in HASM cells. The primary requirement for lamellipodia formation is the activation of small guanosine triphosphate hydrolase (GTPase) Rac1 within minutes of extracellular stimuli 16 . In order to confirm the role of Rac1 in microscopic changes observed in actin cytoskeleton, we performed luminescencebased G-LISA TM assay (Cytoskeleton Inc., Denver, CO) in the cell lysates prepared upon TSLP stimulation (10 ng/ml) (See Methods section). As shown in Fig. 4 , TSLP stimulation induced marked increase in Rac1 activity over the unstimulated control. As a positive control, PDGF also led to enhanced Rac1 activity in HASM cells (Fig. 4) . Collectively, our data suggest that TSLPinduced HASM cell migration may occur potentially via Rac1 activation and actin cytoskeleton rearrangement.
Discussion
The data presented here uniquely shows a pro-migratory function of TSLP in HASM cells. TSLP-induced HASM cell migration was dependent upon STAT3 activity as shown by lentiviral-shRNAmediated STAT3 inhibition experiments. Further analysis showed that TSLP invokes necessary cytoskeleton rearrangements such as formation of lamellipodia, cell polarization, and enhanced activity of small GTPase Rac1. Collectively, we show that TSLP may induce pro-migratory function in human ASM cells.
Migration of smooth muscle occurs during tube formation of hollow organs including blood vessels, gastrointestinal tract, and airways 17 . A similar phenomenon of migration of smooth muscle of airways has been proposed to happen in response to tissue injury, inflammation, and underlies airway remodeling 17 . Although ASM cells from asthmatic subjects have been shown to exhibit increased proliferative capacity than from non-asthmatics 18 , it is currently unknown whether the migratory potential is also altered between two groups. However, stimulation of ASM with some growth factors and cytokines, found to be increased in asthmatic airways such as IL-8/CXCL8, TGF-b, PDGF-BB, and extracellular matrix components collagens, fibronectin, and laminin, promotes cell migration 19 . By showing that TSLP can induce HASM cell migration, we add a new pro-migratory factor to this list. Although our data does not essentially confirm a role for TSLP in the pathogenesis of airway remodeling, we provide at least one mechanism through which HASM cell migration could occur. Interestingly, we also found that TSLP can induce a modest level of proliferation in HASM cells (N. S. Redhu, L. Shan, and A. S. Gounni, unpublished observations). Therefore, this data provides a strong rationale for further studies in animal models to assess the role of TSLP in airway smooth muscle remodeling. In support of our proposal, a recent study using house dust mite (HDM) allergen-induced asthma model showed that neutralization of TSLP with anti-TSLP mAb reversed the airway inflammation, prevented structural alterations, and decreased the pro-remodeling cytokine TGF-b expression and AHR to methacholine 20 . However, further studies are required to confirm a specific role of TSLP in increased ASM mass in context of cell migration while considering other important phenomenon of ASM hypertrophy and hyperplasia. Although TSLP has recently emerged as a direct player in initiation of allergic inflammatory responses, it was initially recognized as a growth factor and mitogen for pro-B cell line Ba/F3 21 . It should also be noted that TSLP expression is increased in COPD and allergic asthma airways including the smooth muscle tissue 10, 11, 22 . It is now clear that TSLP can stimulate myeloid and lymphoid cells, eliciting the proliferation of naïve T cells, pro-and pre-B cells, and migration of dendritic cells (DCs) 23, 14, 24 . TSLP also rescued the eosinophils from apoptosis and enhanced the surface adhesion molecules, inflammatory gene expression, and cell chemotaxis 25 . We have earlier demonstrated a critical role of TSLP in wound repair, proliferation, and migration of airway epithelial cells in allergic asthma 26 . TSLPinduced migration of HASM cells in this study extends the role of TSLP as a potent pro-remodeling regimen in airway disease. Although not fully understood, signaling mechanisms activated by TSLP are becoming increasingly known. STAT3 is one of the critical signaling molecules that have been implicated in promoting allergic inflammation. In particular, a predominant role of STAT3 was shown in studies where epithelial STAT3 disruption led to controlled airway eosinophilia 27 , and IL-17A induced the eotaxin-1/CCL11 (an eosinophil mobilizing chemokine) expression in HASM cells 28 . Although both STAT3 and STAT5 have been shown to be activated in response to TSLPR activation, STAT5 is considered as a signature signaling dock for TSLP in hematopoietic cells 6 . However, STAT3 but not STAT5 is phosphorylated and only STAT3 activation was required for TSLP-induced HASM cell synthetic functions 12 . In current report, TSLP-induced migration was abrogated in STAT3-silenced HASM cells, suggesting that STAT3 serves as an essential signaling mediator.
The process of cell migration is initiated by activation of receptors such as G protein-coupled receptors (GPCRs), receptor tyrosine kinases (RTK), and integrins which trigger the remodeling of cytoskeleton, discussed in context of HASM cell migration extensively in 17 . Actin polymerization is a proximal event that propels the leading edge of the cell towards the stimulus. The small G proteins such as Ras, Rac, Rho, and Cdc42 are prominent early signaling elements that promote cell migration. In our results, TSLP clearly induced polarized state of HASM cells, and formation of lamellipodia confirmed the initial events required for cell migration. Furthermore, TSLP induced a significant level of Rac1 activity in HASM cells. Although Rac family members are known to be involved in proliferation of ASM cells 29 , their role in ASM cell migration is unknown 17 . Moreover, Rac1 and Rac2 have been shown earlier to mediate PDGFinduced migration in vascular smooth muscle (VSM) cells 30 . Our data shows that PDGF-induced Rac1 activation may indeed be required for HASM cell migration. In summary, this data demonstrates that TSLP and PDGF-BB may induce HASM cell migration by inducing key structural changes including actin polymerization and Rac1 activity.
Taken together, as the appreciation for the role of TSLP in initiation and/or perpetuation of airway inflammation is growing, current report underscores a potential pro-remodeling function of TSLP. TSLP-induced HASM cell migration involves STAT3 activity, actin polymerization, cell polarization, and Rac1 activity. It is highly likely that locally produced TSLP in airways (from ASM, epithelium, and/or mast cells), besides activating the DCs to shape the inflammatory Th2 differentiation, can act in an autocrine/paracrine manner to directly induce local ASM and epithelial tissue remodeling, prominent in allergic asthma. Therefore, strategies targeting the TSLP, its receptor, or signaling components may additionally be considered for trials in airway remodeling.
Methods
Reagents. Recombinant human TSLP and PDGF-BB were purchased from R&D Systems (Minneapolis, MN) . FBS was from HyClone Laboratories (Logan, UT). DMEM, Ham's F12, trypsin-EDTA, antibiotics (penicillin, streptomycin), were from Invitrogen Life Technologies (Grand Island, NY). All other reagents were procured from Sigma-Aldrich Canada Ltd. (Oakville, ON) , unless specified.
Preparation and stimulation of human airway smooth muscle (HASM) cells. Three different sources of HASM cells were used. Written informed consent was obtained from the tissue donors, and this study was approved by the research ethics committee of the University of Manitoba, Winnipeg, Canada. Both hTERTimmortalized and primary human bronchial smooth muscle (HBSM) cells were prepared as described previously 12, 31, 32 . Primary human tracheal smooth muscle (HTSM) cells were kindly provided by Dr. Thomas Murphy, Department of Pediatrics, Duke University Medical Center, Durham, NC. HTSM cells were cultured and maintained in a similar method as primary HBSM cells 32, 33 . In all the experiments, primary HASM cells were used at passages 2-6, and hTERT cells at passages 10-30. Sub-confluent HASM cells were growth arrested and synchronized by serum deprivation for 48 h in Ham's F-12 medium containing 1X ITS (5 mg/ml human recombinant insulin, 5 mg/ml human transferrin, 5 ng/ml selenium) (Invitrogen), and antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin). Cells were then stimulated in fresh FBS-free F-12 medium containing recombinant human TSLP (1, 10 ng/ml), PDGF-BB (10 ng/ml), or medium alone for indicated time periods.
Boyden chamber cell migration assay. HASM cell migration was analyzed by using Boyden chamber assay as described previously 34 . Briefly, 48 h serum-deprived cells were detached from the culture plate using trypsin-EDTA solution (Invitrogen Canada Inc., Burlington, ON) and resuspended in Ham's F12 medium containing antibiotics, and 1X ITS. A polycarbonate membrane of 8 mm pore size (Neuroprobe, Gaithersburg, MD, USA) was coated with 0.01% collagen type-I in 0.01N HCl solution (Sigma). A 50 ml aliquot of HASM cells (5 3 10 4 cells/ml) was added to the upper chamber of modified Boyden chamber apparatus (Neuroprobe). In the lower chamber, TSLP (1, 10 ng/ml) or PDGF-BB (10 ng/ml) were added as chemoattractant to the same media as the upper chamber. After 4 h of incubation at 37uC in humidified 5% CO 2 incubator, the membranes were peeled-off. Cells on the upper side of the membrane were scraped off and the cells migrated to the lower side were fixed and stained with HemacolorH stain set (EMD Millipore, Billerica, MA, USA). The number of migrated cells was counted in four-five random fields under X20 magnification by phase contrast microscope (Carl Zeiss Canada Ltd., Toronto, ON).
Lentivirus-mediated STAT3-shRNA transduction in HASM cells. Lentiviral transduction of STAT3-short hairpin (sh) RNA (clone ID: V2LHS_262105) in HASM cells was performed as described earlier 12 . The average transduction efficiency was greater than 95%, analyzed by flow cytometry using the turbo green fluorescent protein (tGFP) as the marker for cell sorting (data not shown) and 12 . STAT3 expression in lentivirus-transduced cells was significantly reduced as shown by Western blotting (Figure 2A ). Mock and lentiviral-STAT3-shRNA transduced HASM cells were cultured in the presence of TSLP (1, 10 ng/ml), PDGF-BB (10 ng/ml), or medium alone. Cell migration was assessed by Boyden chamber assay as described above.
Phalloidin staining to measure actin polymerization. Immunofluorescence and confocal laser scanning microscopy was performed as we described previously 12 . To minimize the activation of cytoskeleton by nonspecific stimuli, physical manipulation of slides was kept to minimum. In brief, HASM cells were grown on 24-well glass slides (Nalge Nunc International, Naperville, IL) up to semi-confluence and stimulated with TSLP (10 ng/ml), PDGF (10 ng/ml) or media alone for 5-30 min. Slides were then fixed with 4% paraformaldehyde for 30 min, and stained with phalloidin-Alexa Fluor 488 (Invitrogen) for 30 min at room temperature in dark and analyzed by confocal microscopy.
Measurement of GTPase Rac1 activity. Levels of small GTPase Rac1 were measured by a luminescence based G-LISA Rac1 activation assay biochem kit (Cat # BK126; Cytoskeleton, Denver, CO, USA). Briefly, 48 h serum-deprived HASM cells were cultured in presence of TSLP (10 ng/ml) and PDGF (10 ng/ml) and cell lysates were prepared at the indicated times by following the G-LISA kit manufacturer protocol. Luminescence in cell lysates was measured and relative luminescence units (RLU) were determined from experiments performed at least in duplicate.
Statistical analysis. All the data were obtained from experiments performed at least in triplicate. Statistical analysis was performed by using GraphPad Prism Software Version 3.02 for Windows (GraphPad Software, San Diego, CA, USA). Data between groups was compared by using one-way analysis of variance (ANOVA) followed by Newman-Keuls multiple comparison test. P values , 0.05 were considered statistically significant. 
